Luigi Mangione won't face death penalty after US judge dismisses murder charge

Reuters01-30 23:30
UPDATE 3-Luigi Mangione won't face death penalty after US judge dismisses murder charge

Judge says murder charge incompatible with stalking charges

Mangione faces possible life in prison on remaining federal charges

US hasn't decided whether to appeal

Judge won't suppress contents of Mangione's backpack

Mangione still faces New York state murder case

Adds hearing details, separate ruling on Mangione's backpack, background on Thompson killing, paragraphs 2-4, 9, 15-17

By Jack Queen and Jonathan Stempel

NEW YORK, Jan 30 (Reuters) - Luigi Mangione will not face the death penalty after a U.S. judge on Friday dismissed murder and weapons charges against the accused killer of UnitedHealthcare CEO Brian Thompson, in a major blow to federal prosecutors.

U.S. District Judge Margaret Garnett in Manhattan said she felt constrained by Supreme Court precedents to dismiss the murder charge, saying it was legally incompatible with the two stalking charges Mangione still faces, while acknowledging that ordinary people might be dumbfounded by the outcome.

Mangione, 27, still faces possible life in prison without the possibility of parole if convicted on the stalking charges.

Dominic Gentile, a federal prosecutor, told Garnett at a routine court hearing on Friday the government has not decided whether it will appeal.

Thompson, who led UnitedHealth Group's UNH.N health insurance business, was shot and killed on December 4, 2024 outside the Hilton hotel in midtown Manhattan.

Mangione pleaded not guilty to all charges stemming from Thompson's death, and has been jailed since his arrest in Pennsylvania five days after the killing.

While public officials widely condemned Thompson's killing, Mangione became a folk hero of sorts to many Americans who decry high costs for medical care and health insurer practices.

Garnett has scheduled jury selection in the case to begin in September, with the evidence phase of trial beginning October 12.

Mangione has also pleaded not guilty to separate murder, weapons and forgery charges in a New York state court in Manhattan.

No trial date in that case has been set. Prosecutors in that case suffered their own setback in September, when the judge dismissed two terrorism-related counts against Mangione.

JUDGE ACKNOWLEDGES 'TORTURED AND STRANGE' LEGAL ANALYSIS

In a 39-page decision, Garnett said federal prosecutors could pursue their murder and weapons charges only if the stalking charges qualified as "crimes of violence."

She said the charges did not qualify because any use of force could be achieved through reckless, as opposed to intentional, conduct.

The judge said prosecutors and Mangione agreed that this fell short of the kind of "force" the Supreme Court required to make out a crime of violence.

Garnett acknowledged the "apparent absurdity" of the legal landscape, saying no one would seriously question that Mangione's alleged conduct -- crossing state lines to kill a specific healthcare executive with a handgun equipped with a silencer -- was violent criminal conduct.

She said her analysis may strike ordinary people, and many lawyers and judges, as "tortured and strange," but it "represents the court's committed effort to faithfully apply the dictates of the Supreme Court to the charges in this case. The law must be the court's only concern."

In a separate decision, Garnett rejected Mangione's bid to exclude evidence seized from his backpack when he was arrested.

Mangione argued that evidence found in the backpack, including a 9-millimeter pistol, silencer and journal entries, should be suppressed because police obtained it without a warrant.

The judge said it was standard practice for local police to search closed bags that might reasonably contain dangerous objects, and the police had probable cause to conduct a search. She also said the contents would have been discovered inevitably through a federal search warrant.

(Reporting by Jack Queen and Ryan Patrick Jones; editing by Susan Heavey, Chizu Nomiyama and Bill Berkrot)

((sheavey@thomsonreuters.com; +1-202-898-8300;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment